JNJ-SELL strategy 9 hourly KagiThis share is negative at the moment, and it is possible to see a test of the BUY zone area $ 151.00 - $ 145.00.
Strategy SELL current $ 160-165 and take profit near $ 145.00
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
5.48 EUR
12.84 B EUR
77.15 B EUR
2.40 B
About Johnson & Johnson
Sector
CEO
Joaquin Duato
Headquarters
New Brunswick
Website
Founded
1887
FIGI
BBG01K3XQNH1
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
$JNJ with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:JNJ after a negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 100%.
Bullish on JNJHello All!
JNJ looks like it could make a new high. The confluences I like are: JNJ made a high on the daily, retraced back to 159.00 creating a new Higher Low. Considering that price didn't break structure to the downside, and reversed in the 78.6% Fib indicates to me that price may be heading up.
$JNJ Balls to the WallAs we can see, NYSE:JNJ has been following a regular down trend April 2022 and has no significant move to break upwards until recently.
On the monthly chart, we have a solid sideways consolidation after a strong movement up indicating the possibility monthly demand.
Considering the strong bull
JOHNSON & JOHNSON Excellent confirmed sell signalJohnson & Johnson (JNJ) gave us the most optimal buy entry on our last call (April 17, see chart below) and easily hit our 157.50 Target:
Having been rejected early in September exactly at the top (Lower Highs trend-line) of the 2-year Channel Down and now establishing price action below its 1D
Bear for Johnson & Johnson confluence & fundamental
bear for the sell; technical analysis and fundamental is very important, when doing top down analysis and your confluences add up you pretty much knows what the chart going to do.
NEW RELEASE:The 3 Step Rocket Booster StrategyYes its been a while since you saw me talking about
my #1 favourite strategy of all time.
This strategy is very simple and easy to follow
-
And in this article am going to teach it to you.
Because it only has 3 steps, according to this
stock NYSE:JNJ
-
-The price has to be above the 50 EMA
-
JNJ-SELL strategy 3-Daily chart Heikin AshiI feel this share is coming under pressure, its overbought and turning negative.
Strategy SELL @ $ 163-165 and take profit near $ 150.00. SL based on personal risk parameters.
JNJ LongDemand Zone
Long 152.40
Stop 145
Target 162, 173
Risk management is much more important than a good entry point.
I am not a PRO trader.
In my trading plan, the Max Risk of each short term trade should be less than 1% of an account.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where 1JNJ is featured.
Frequently Asked Questions
The current price of 1JNJ is 145.64 EUR — it hasn't changed in the past 24 hours. Watch JOHNSON & JOHNSON stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange JOHNSON & JOHNSON stocks are traded under the ticker 1JNJ.
1JNJ stock has fallen by −1.45% compared to the previous week, the month change is a −1.57% fall, over the last year JOHNSON & JOHNSON has showed a 4.70% increase.
We've gathered analysts' opinions on JOHNSON & JOHNSON future price: according to them, 1JNJ price has a max estimate of 196.73 EUR and a min estimate of 145.49 EUR. Watch 1JNJ chart and read a more detailed JOHNSON & JOHNSON stock forecast: see what analysts think of JOHNSON & JOHNSON and suggest that you do with its stocks.
1JNJ reached its all-time high on Oct 22, 2024 with the price of 155.96 EUR, and its all-time low was 131.56 EUR and was reached on May 28, 2024. View more price dynamics on 1JNJ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1JNJ stock is 0.38% volatile and has beta coefficient of −0.02. Track JOHNSON & JOHNSON stock price on the chart and check out the list of the most volatile stocks — is JOHNSON & JOHNSON there?
Today JOHNSON & JOHNSON has the market capitalization of 349.23 B, it has decreased by −1.45% over the last week.
Yes, you can track JOHNSON & JOHNSON financials in yearly and quarterly reports right on TradingView.
JOHNSON & JOHNSON is going to release the next earnings report on Jan 28, 2025. Keep track of upcoming events with our Earnings Calendar.
1JNJ earnings for the last quarter are 2.17 EUR per share, whereas the estimation was 1.98 EUR resulting in a 9.68% surprise. The estimated earnings for the next quarter are 1.88 EUR per share. See more details about JOHNSON & JOHNSON earnings.
JOHNSON & JOHNSON revenue for the last quarter amounts to 20.18 B EUR, despite the estimated figure of 19.91 B EUR. In the next quarter, revenue is expected to reach 20.96 B EUR.
1JNJ net income for the last quarter is 2.42 B EUR, while the quarter before that showed 4.37 B EUR of net income which accounts for −44.69% change. Track more JOHNSON & JOHNSON financial stats to get the full picture.
Yes, 1JNJ dividends are paid quarterly. The last dividend per share was 1.11 EUR. As of today, Dividend Yield (TTM)% is 3.13%. Tracking JOHNSON & JOHNSON dividends might help you take more informed decisions.
JOHNSON & JOHNSON dividend yield was 3.00% in 2023, and payout ratio reached 84.93%. The year before the numbers were 2.52% and 66.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 12, 2024, the company has 131.90 K employees. See our rating of the largest employees — is JOHNSON & JOHNSON on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JOHNSON & JOHNSON EBITDA is 25.92 B EUR, and current EBITDA margin is 34.82%. See more stats in JOHNSON & JOHNSON financial statements.
Like other stocks, 1JNJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JOHNSON & JOHNSON stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JOHNSON & JOHNSON technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JOHNSON & JOHNSON stock shows the neutral signal. See more of JOHNSON & JOHNSON technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.